학술논문
Results of a phase 2a, multicenter, open-label, study of RM-1929 photoimmunotherapy (PIT) in patients with locoregional, recurrent head and neck squamous cell carcinoma (rHNSCC).
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755